THE COURSE OF NEUROCOGNITIVE PERFORMANCE OVER FOUR YEARS IN WELL-TREATED PLWH
Background: Among people living with HIV (PLWH) enrolled in the Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study, we have observed a neurocognitive impairment (NCI) prevalence of 40% by Frascati criteria. However, most patients have asymptomatic neurocognitive impairment (ANI), and analysed trajectories at two-years follow-up showed no signs of decline. In the current…